Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Growth comes from focusing on segments we can win now, then expanding systematically as the system proves itself.

In the dynamic environment of small to medium enterprises and startups, leaders often face a barrage of tasks demanding immediate attention. The Eisenhower Matrix, a strategic prioritization tool, ...

Marketing used to rely a lot more on gut feeling. Creative directors would dream up campaigns over long lunches, and my team and I would blast messages to anyone who'd listen. We called it ...

With markets from Tokyo to New York on edge this week, the warning sign flashing around a large Mumbai builder didn’t get much attention. But Indian investors were keeping a close eye. When Oberoi ...

The H-2A program continues to grow, with 13,358 more positions certified in fiscal year 2025 (October 2024-September 2025) than fiscal year 2024. This marks the first year in program history that over ...

AI use is skyrocketing, and new tools are entering the scene every day. No wonder that many leaders are concerned about the ethical implications of AI in marketing. Let's kick things off by talking ...

The stock market in President Donald Trump’s first year back in the White House was the weakest of any president’s first year of a new term since 2005, when George W. Bush started his second term.

Gold and silver prices have struck consecutive record highs this year, but some analysts are warning that speculative flows are amplifying moves. Thin market depth means modest inflows can trigger ...